Position in EXEL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,100,662
+$656,490 QoQ
Shares Held
56,987
0.0% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#221
of 754 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026South Dakota Investment Council holds $23,963,141 across 6 Biotechnology names. EXEL ranks #4 (12.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,578 | $9,089,966 | |
| 2 | MRNA |
Moderna, Inc.
|
58,371 | $4,087,721 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,760 | $3,357,894 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
56,987 | $3,100,662 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
28,888 | $2,261,063 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
8,573 | $2,065,835 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,100,662 | 56,987 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,444,172 | 56,987 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $2,497,740 | 56,987 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,506,373 | 60,687 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,913,114 | 66,087 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $2,439,932 | 66,087 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,330,567 | 69,987 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,816,162 | 69,987 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,572,607 | 69,987 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $4,249,046 | 179,058 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $4,408,354 | 183,758 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $4,015,112 | 183,758 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $3,578,500 | 187,258 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,593,994 | 185,162 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,488,798 | 155,162 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,976,652 | 126,062 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,624,610 | 126,062 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $7,904,258 | 348,666 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $10,301,364 | 563,532 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $11,913,066 | 563,532 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $8,489,281 | 465,932 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $10,738,427 | 475,362 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $8,757,725 | 436,359 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $10,668,977 | 436,359 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $10,552,168 | 444,489 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $8,151,810 | 473,392 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||